6505--LENALIDOMIDE CAPSULES - Pharmacy, Cleveland

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 10, is seeking an authorized distributor of Lenalidomide Capsules for the VA Northeast Ohio Healthcare System serving the Louis Stokes Cleveland VAMC. Lenalidomide is an immunomodulatory medication used to treat certain blood cancers and related disorders and is subject to strict Risk Evaluation and Mitigation Strategy (REMS) requirements, mandating dispensing only through certified pharmacies. Vendors must be authorized distributors of the product, demonstrate capability to provide all required items, obtain necessary licensure prior to submission, and cannot supply grey market items. The RFQ does not specify formal evaluation criteria beyond vendor qualifications and capability demonstration. Key deadlines include January 17, 2026, at 09:00 EST for submission of questions directed to Contracting Officer Robert Blasko, and January 20, 2026, at 09:00 EST for RFQ responses via email with the subject line "RFQ 36C25026Q0139."

This solicitation carries no set-aside designation and does not identify any incumbent contractor. The procurement specifies generic Lenalidomide in six strength variants: 2.5mg (45 packages), 5mg (70 packages), 10mg (185 packages), 15mg (75 packages), 20mg (10 packages), and 25mg (30 packages), with package quantities ranging from 21 to 28 capsules per unit. The contract period covers the entire calendar year 2026, with specific performance dates to be established at the time of award. No award value or budget range is disclosed in the presolicitation notice. Respondents are instructed to submit uncompressed documents via email rather than .zip files due to email security constraints, and the government will not compensate vendors for costs incurred in developing response information.